Financial News

My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Minerva Neurosciences, Inc - Common Stock (NQ:NERV)

2.650 -0.180 (-6.36%)
Streaming Delayed Price Updated: 11:12 AM EDT, Oct 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Minerva Neurosciences, Inc - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Dow Tumbles 150 Points; Crude Oil Falls Sharply
U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 150 points on Wednesday. 
Via Benzinga
US Stocks Rise; Dow Gains 100 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Wednesday. 
Via Benzinga
Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia
From Minerva Neurosciences, Inc
Via GlobeNewswire
Minerva Neurosciences Shares Sink On Regulatory Setback For Schizophrenia Candidate
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
Greater Prevalence of Anxiety & Depressive Disorders Driving Demand for New Anti-Anxiety Drug Candidates
EQNX::TICKER_START (NASDAQ:SAGE),NASDAQ:NERV),(NASDAQ:ATAI),(NYSE:CYBN),(TSXV:MRVL),(NEO:CYBN), EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Retirement
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022
Upgrades 
Via Benzinga
Minerva Neurosciences Reports Third Quarter 2022 Financial Results and Business Updates
Company To Host Live Webcast Today at 8:30 a.m. ET 
From Minerva Neurosciences, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Merrimack Pharmaceuticals (NASDAQ:MACK) shares rose 180.0% to $11.2 during Wednesday's pre-market session. The company's market cap stands at $150.1 million. As per the news, the Q3 earnings... 
Via Benzinga
Minerva Neurosciences to Report Third Quarter 2022 Financial Results and Business Updates on November 9, 2022
From Minerva Neurosciences, Inc
Via GlobeNewswire
Why IBM Shares Are Trading Higher; Here Are 21 Stocks Moving Premarket
Gainers COMSovereign Holding Corp. (NASDAQ: COMS) rose 20.9% to $0.1063 in pre-market trading after dipping 26% on Wednesday. COMSovereign recently announced receipt of Nasdaq listing determination. 
Via Benzinga
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case. 
Via Benzinga
Dow Rises Over 2%; S&P 500 Up 100 Points
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 300 points on Monday. 
Via Benzinga
Virgin Orbit And 4 More Short Squeeze Stocks That Could Soar This Week — Including A Stock Moving Up 968 Positions
Potential short squeeze plays gained steam in 2021 and has continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates based on the... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers 
Via Benzinga
Nasdaq Jumps 300 Points; Bank of America Tops Q3 Estimates
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 300 points on Monday. 
Via Benzinga
Why Bank of America Shares Are Trading Higher? Here Are 66 Stocks Moving In Monday's Mid-Day Session
Gainers FedNat Holding Company (NASDAQ: FNHC) shares rose 78.9% to $0.93 after jumping 48% on Friday. 
Via Benzinga
GLSI, AVTE: The Top 5 Short Squeeze Stocks to Watch This Week
Short-squeeze stocks continue to be a big deal for speculative traders and we're helping them out with a list to keep in mind this week! 
Via InvestorPlace
Looking Into Minerva Neurosciences's Recent Short Interest
Minerva Neurosciences's (NASDAQ:NERV) short percent of float has fallen 47.4% since its last report. The company recently reported that it has 573 thousand shares sold short, which is 14.49% of all... 
Via Benzinga
US Stocks Open Higher; Dow Surges 500 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining around 500 points on Monday. 
Via Benzinga
Minerva Neurosciences Receives Refusal to File Letter from FDA for its New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia
From Minerva Neurosciences, Inc
Via GlobeNewswire
TOP Ships, Weber And 3 More Short Squeeze Stocks That Could Soar This Week
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates based on the... 
Via Benzinga
Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday
Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday. 
Via Benzinga
TOPS, SURG: The Top 5 Short Squeeze Stocks This Week
Short squeeze stocks are still popular with speculative traders and that has us going over the top ones to keep an eye on this week! 
Via InvestorPlace
How Is The Market Feeling About Minerva Neurosciences?
Minerva Neurosciences's (NASDAQ:NERV) short percent of float has fallen 31.87% since its last report. The company recently reported that it has 1.09 million shares sold short, which is 27.55% of all... 
Via Benzinga
10 Short Squeeze Candidates That May Soar: Minerva Neurosciences, FaZe, Getty Images And More
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. 
Via Benzinga
NERV, FAZE: The Top 5 Short Squeeze Stocks This Week
Short squeeze stocks are still worth tracking as traders look for potential gains this week and we've got a list of potential targets! 
Via InvestorPlace
NRBO, FAZE: The Top 5 Short Squeeze Stocks to Watch This Week
Traders continue to show interest in short squeeze stocks this week as they seek out likely targets that will run higher. 
Via InvestorPlace
5 Short Squeeze Stocks That Could Soar: NeruoBo Pharmaceuticals, FaZe Holdings And More
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates for the week... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback